Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Transalta (TACPF) EBITDA (2016 - 2025)

Historic EBITDA for Transalta (TACPF) over the last 17 years, with Q3 2025 value amounting to $8.0 million.

  • Transalta's EBITDA fell 8802.09% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $391.0 million, marking a year-over-year decrease of 4540.1%. This contributed to the annual value of $1.3 billion for FY2024, which is 2322.3% down from last year.
  • Per Transalta's latest filing, its EBITDA stood at $8.0 million for Q3 2025, which was down 8802.09% from -$2.0 million recorded in Q2 2025.
  • In the past 5 years, Transalta's EBITDA registered a high of $541.0 million during Q4 2022, and its lowest value of -$324.9 million during Q3 2021.
  • Moreover, its 5-year median value for EBITDA was $88.6 million (2023), whereas its average is $123.5 million.
  • In the last 5 years, Transalta's EBITDA tumbled by 39201.52% in 2021 and then soared by 6562117056.57% in 2024.
  • Transalta's EBITDA (Quarter) stood at $19.8 million in 2021, then surged by 2627.72% to $541.0 million in 2022, then tumbled by 46.58% to $289.0 million in 2023, then decreased by 1.38% to $285.0 million in 2024, then tumbled by 97.2% to $8.0 million in 2025.
  • Its EBITDA was $8.0 million in Q3 2025, compared to -$2.0 million in Q2 2025 and $100.0 million in Q1 2025.